Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry
AbstractBackground: Little is known about the extent of impairments in work and activities of daily life (ADL) in patients with psoriasis, and the influence of contextual factors such as disease-related characteristics and treatment. Therefore, this study aimed to assess these impairments in patient...
Saved in:
Main Authors: | Tamara W. van Hal (Author), Juul M. P. A. van den Reek (Author), Mark H. Wenink (Author), Marisol E. Otero (Author), Paul M. Ossenkoppele (Author), Marcellus D. Njoo (Author), Annet Oostveen (Author), Bas Peters (Author), Milan Tjioe (Author), Else N. Kop (Author), John E. M. Körver (Author), Sharon R. P. Dodemont (Author), Marloes M. Kleinpenning (Author), Maartje A. M. Berends (Author), Wendelien R. Veldkamp (Author), Martijn B. A. van Doorn (Author), Johannes M. Mommers (Author), Robert-Jan Lindhout (Author), Astrid L. A. Kuijpers (Author), Paula P. van Lümig (Author), C. (Els) (Author), Ron A. Tupker (Author), Judith Hendricksen (Author), Romy R. Keijsers (Author), Frank H. J. van den Hoogen (Author), Johanna E. Vriezekolk (Author), Elke M. G. J. de Jong (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry
by: Lara S. van derSchoot, et al.
Published: (2022) -
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
by: Marloes E. van Muijen, et al.
Published: (2022) -
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study
by: Selma Atalay, et al.
Published: (2020) -
Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis
by: M. J. H. Voshaar, et al.
Published: (2022) -
Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design
by: A. M. van Hulst, et al.
Published: (2021)